ResearcherTUM KlinikumActive in the last 2 years
Sebastian Mueller
Matched on ORCID iD 0009-0008-1514-3027; OpenAlex author ID A5101817512. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 55
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 5
- The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70794↗
- A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development. Co-author DOI 10.1038/s41467-025-56493-7↗
- Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41551-024-01273-9↗
- A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2020-321397↗
- Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. Co-author DOI 10.1038/nature25459↗
Closest collaborators
The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roland Rad · 5 shared papers, 2018–2026 · strength 0.67
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
- Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
- Roland Michael Schmid · 4 shared papers, 2018–2026 · strength 0.55
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
- Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
- Dieter Saur · 4 shared papers, 2018–2026 · strength 0.51
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
- Paper A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic ca… DOI 10.1136/gutjnl-2020-321397↗
- Maximilian Reichert · 3 shared papers, 2025–2026 · strength 0.50
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
- Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
- Günter Schneider · 3 shared papers, 2018–2026 · strength 0.39
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
- Paper Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. DOI 10.1038/nature25459↗
- Christian Schneeweis · 2 shared papers, 2025–2026 · strength 0.34
- Aristeidis Papargyriou · 2 shared papers, 2025 · strength 0.32
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
- Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
- Sebastian Lange · 2 shared papers, 2018–2025 · strength 0.20
- Michael B. Ghadimi · 1 shared paper, 2026 · strength 0.19
- Marian Grade · 1 shared paper, 2026 · strength 0.19
- Felix Orben · 1 shared paper, 2026 · strength 0.19
- Ulrich Bernd Keller · 1 shared paper, 2026 · strength 0.19
- Lukas Krauß · 1 shared paper, 2026 · strength 0.19
- Constanza Tapia Contreras · 1 shared paper, 2026 · strength 0.19
- Carolin Schneider · 1 shared paper, 2026 · strength 0.19
- Oliver Holger Krämer · 1 shared paper, 2026 · strength 0.19
- Hazal Köse · 1 shared paper, 2026 · strength 0.19
- Janine Murr · 1 shared paper, 2026 · strength 0.19
- Alexandra Nguyen · 1 shared paper, 2026 · strength 0.19
- Elisabeth Heßmann · 1 shared paper, 2026 · strength 0.19
- Matthias Wirth · 1 shared paper, 2026 · strength 0.19
- Volker Ellenrieder · 1 shared paper, 2026 · strength 0.19
- Marina Lesina · 1 shared paper, 2025 · strength 0.16
- Anne T. Schneider · 1 shared paper, 2025 · strength 0.16
- Thilo Hackert · 1 shared paper, 2025 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.